Brompton Funds: Cash Flow Kings ETF

Brompton's Cash Flow Kings ETFs target high cash flow yielding companies, ensuring strong returns and financial stability for investors.

Brompton Funds: Cash Flow Kings ETF

Brompton's Cash Flow Kings ETFs focus on high free cash flow yielding companies, emphasizing financial strength and shareholder value. According to Brompton's latest report, companies with high free cash flow are not only more financially stable but also outperform the broader equity market. The Cash Flow Kings ETFs invest in quality mid- to large-cap companies with the highest free cash flow yields (excluding financials due to the complexity in defining their cash flow metrics).

The Brompton Cash Flow Kings ETFs (KNGC, KNGU, KNGX) are designed to replicate the Brompton Index One Cash Flow Kings Indices. These indices track the performance of Canadian, US, and International companies with robust free cash flow relative to their enterprise value. With a low management fee of 0.45% (KNGC/KNGU) or 0.55% (KNGX), these ETFs offer a cost-effective way to gain exposure to attractively valued equities. By investing in high free cash flow companies, your portfolio benefits from both growth opportunities and financial stability, making it a smart choice for investors looking to enhance their returns.

‍For more information on Brompton Cash Flow Kings ETFs please view their video HERE.

Published by BTV - The Agency

Discover Investment Opportunities with BTV. Delivering engaging content to Investors for 25+ years. Visit b-tv.com.

You might also like

Picard Medical Advancing Total Artificial Heart Technology
Health & Wellness
March 11, 2026

Picard Medical Advancing Total Artificial Heart Technology

The potential need for technologies like total artificial hearts remains significant as the number of patients with advanced heart failure continues to outpace the availability of donor organs.

This is some text inside of a div block.
Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine
Health & Wellness
March 3, 2026

Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine

Advanced heart failure continues to rise globally, while the supply of donor hearts remains limited. This structural imbalance creates a significant and expanding market opportunity, with thousands of patients each year lacking viable treatment options and placing growing economic pressure on healthcare systems.

This is some text inside of a div block.
Titan Mining: Strengthening America’s Critical Mineral Supply Chain
Metals & Mining
January 28, 2026

Titan Mining: Strengthening America’s Critical Mineral Supply Chain Copy

As the U.S. continues to import 100% of its natural graphite—a vital component in energy storage, defense, and advanced manufacturing—Titan Mining is rising to the challenge.

This is some text inside of a div block.